SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641489-24-000023
Filing Date
2024-04-25
Accepted
2024-04-25 16:23:13
Documents
22
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A vtvt-20240425.htm   iXBRL DEF 14A 846221
6 GRAHPIC vtvt-20240425_g1.jpg GRAPHIC 684980
7 GRAHPIC vtvt-20240425_g2.jpg GRAPHIC 120640
8 GRAHPIC vtvt-20240425_g3.jpg GRAPHIC 163380
9 GRAHPIC vtvt-20240425_g4.jpg GRAPHIC 119019
10 GRAHPIC vtvt-20240425_g5.jpg GRAPHIC 112781
11 GRAHPIC vtvt-20240425_g6.jpg GRAPHIC 105282
12 GRAHPIC vtvt-20240425_g7.jpg GRAPHIC 1361116
13 GRAHPIC vtvt-20240425_g8.jpg GRAPHIC 466924
  Complete submission text file 0001641489-24-000023.txt   8762277

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20240425.xsd EX-101.SCH 3031
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20240425_def.xml EX-101.DEF 4282
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20240425_lab.xml EX-101.LAB 4515
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20240425_pre.xml EX-101.PRE 2993
25 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20240425_htm.xml XML 241472
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37524 | Film No.: 24876713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)